Literature DB >> 2932383

Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.

L Mellow, E Sabbadini.   

Abstract

The injection of BCG vaccine in C57BL/6J mice results in the suppression of the generation of cytotoxic T lymphocytes (CTL) in mixed lymphocyte cultures (MLC) and of mitogenic reactions to concanavalin A (Con A). Suppression is mediated by macrophage-like suppressor cells. Since previous work had indicated that suppression involved the inhibition of the production of interleukin-2 (IL-2), the effects of BCG on interleukin-1 (IL-1), a monokine required for IL-2 production, were investigated. It was found that the release of IL-1-like activity in spleen cell cultures stimulated with LPS or Con A was increased by previous BCG treatment of the cell donors. In MLC, the release of IL-1-like activity was also increased by BCG. However, the detection of IL-1-like activity in MLC supernatants was prevented by the presence of a suppressor factor. In this case, the IL-1-like activity could be separated with gel filtration from the suppressor factor which had higher molecular weight. The production of IL-1-like activity by CBA/J spleen cells, which are not suppressed by BCG, was not significantly different from that of C57BL/6J cells, which are markedly suppressed. Moreover, the addition of IL-1 to the BCG-suppressed cultures not only did not restore normal reactivity, but actually further suppressed CTL formation. It was concluded that BCG-induced suppression cannot be attributed to decreased IL-1 activity. The suppressor factor discovered during these investigations may have a role in this type of suppression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932383      PMCID: PMC1453679     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Identification and partial purification of two synergistically acting helper mediators in human mixed leukocyte culture supernatants.

Authors:  J J Farrar; W J Koopman; J Fuller-Bonar
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

2.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

Authors:  G R Klimpel; C S Henney
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

3.  Mode of action of a soluble immune response suppressor (SIRS) produced by concanavalin a-activated spleen cells.

Authors:  T Tadakuma; C W Pierce
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

4.  Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction.

Authors:  M T Scott
Journal:  Cell Immunol       Date:  1972-11       Impact factor: 4.868

5.  On the mode of action of BCG.

Authors:  M S Mitchell; D Kirkpatrick; M B Mokyr; I Gery
Journal:  Nat New Biol       Date:  1973-06-13

6.  Macrophage regulation of DNA synthesis in lymphoid cells: effects of a soluble factor from macrophages.

Authors:  S R Waldman; A A Gottlieb
Journal:  Cell Immunol       Date:  1973-10       Impact factor: 4.868

7.  Production by stimulated macrophages of factors depressing lymphocyte transformation.

Authors:  D S Nelson
Journal:  Nature       Date:  1973-11-30       Impact factor: 49.962

8.  Potentiation of cultured mouse thymocyte responses by factors released by peripheral leucocytes.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

9.  Partial purification of a serum factor that causes necrosis of tumors.

Authors:  S Green; A Dobrjansky; E A Carswell; R L Kassel; L J Old; N Fiore; M K Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

10.  The evolution of immunosuppressive cell populations in experimental mycobacterial infection.

Authors:  W E Bullock; E M Carlson; R K Gershon
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

View more
  2 in total

1.  Induction by an immunogenic immunomodulating agent of nonspecific T cell suppression of lymphocyte responsiveness in MLR but not of antibody production.

Authors:  C Reuben; D Halperin; S Ben-Efraim; D W Weiss
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 2.  The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis.

Authors:  Tandeka Magcwebeba; Anca Dorhoi; Nelita du Plessis
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.